Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 23-27

  Lesauskaite, Vaiva ^a   Sinkunaite Marsalkiene, Giedre ^a   Tamosiunas, Abdonas ^a   Benetis, Rimantas ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Aneurysm; Angiotensin converting enzyme; Matrix metalloproteinase 3; Polymorphism; Thoracic aorta

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; STROMELYSIN;

AORTA DISEASE; ARTICLE; ASCENDING AORTA; CORONARY ARTERY DILATATION; DILATATIVE PATHOLOGY WITHIN THE ASCENDING THORACIC AORTA; DISEASE PREDISPOSITION; ENZYME ACTIVATION; ENZYME POLYMORPHISM; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; LITHUANIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; THORACIC AORTA;

AGED; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 79957985817     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.10.014     Document Type: Article

References (25)

1. Barbour J., Spinale F., Ikonomidis J. Proteinase systems and thoracic aortic aneurysm progression. J Surg Res 2007, 139:292-307.
2. Inoue N., Muramatsu M., Jin D., Takai S., Hayashi T., Katayama H., Kitaura Y., Tamai H., Miyazaki M. Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II-infused ApoE-deficient mice. J Atheros Thromb 2009, 16:164-171.
3. Kamijima T., Isobe M., Suzuki J., Fukui D., Arai M., Urayama H., Nishimaki K., Sekiguchi M., Kawasaki S. Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression. Cardiovasc Pathol 1999, 8:291-295.
4. Page-McCaw A., Ewald J.A., Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol 2007, 8:221-233.
5. Deguara J., Burnand K.G., Berg J., Green P., Lewis C.M., Chinien G., Waltham M., Taylor P., Stern R.F., Solomon E., Smith A. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum Mol Genet 2007, 16:3002-3007.
6. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., Sone T., Tanaka M., Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
7. Shu Y., Eriksson P., Hamstens A., Kurkinen M., Humphries S.E., Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996, 271:13055-13060.
8. Heeneman S., Sluimer J.C., Daemen M.J. Angiotensin-converting enzyme and vascular remodeling. Circ Res 2007, 101:441-454.
9. Wang M., Zhang J., Spinetti G., Jiang L.Q., Monticone R., Zhao D., Cheng L., Krawczyk M., Talan M., Pintus G., Lakatta E.G. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 2005, 167:1429-1442.
10. Rouet-Benzineb P., Gontero B., Dreyfus P., Lafuma C. Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol 2000, 32:1767-1778.
11. Peasey A., Bobak M., Kubinova R., Malyutina S., Pajak A., Tamosiunas A., Pikhart H., Nicholson A., Marmot M. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 2006, 18:255.
12. Sepp R., Szabo I., Uda H., Sakamoto H. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 1994, 47:318-323.
13. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
14. Mayer N.J., Forsynth A., Kantachuvesiri S., Mullins J.J., Fleming S. Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury. J Clin Pathol: Mol Pathol 2002, 55:29-33.
15. Lesauskaite V., Sinkunaite G., Benetis B., Grabauskas V., Vaskelyte J., Smalinskiene A., Simonyte S., Jariene G., Tatarunas V., Klumbiene J., Petkeviciene J., Kinduris S., Giedraitis S., Sakalauskas J., Bolys R., Sirvinskas E., Lenkutis T., Pangonyte D. Matrix metalloproteinase-3 gene polymorphism and dilatative pathology of ascending thoracic aorta. Medicina (Kaunas) 2008, 44:386-391.
16. Ogata T., Shibamura H., Tromp G., Sinha M., Goddard K.A., Sakalihasan N., Limet R., MacKean G.L., Arthur C., Sueda T., Land S., Kuivaniemi H. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 2005, 41:1036-1042.
17. Kalay N., Caglayan O., Akkaya H., Ozdogru I., Dogan A., Inanc M.T., Kaya M.G., Ergin A., Topsakal R., Cicek D., Eryol N.K., Tasdemir K., Oguzhan A., Dundar M. The deletion polymorphism of the angiotensin-converting enzyme gene is associated with acute aortic dissection. Tohuku J Exp Med 2009, 219:33-37.
18. Tangurek B., Ketenci B., Ozay B., Ozer N., Yilmaz H., Sayar N., Ciloglu F., Gorur A., Bolca O. Lack of association between angiotensin-converting enzyme gene polymorphism and type I aortic dissection. J Int Med Res 2008, 36:714-720.
19. Jones G.T., Thompson A.R., van Bockxmeer F.M., Hafez H., Cooper J.A., Golledge J., Humphries S.E., Norman P.E., van Rij A.M. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 2008, 28:764-770.
20. Thompson A.R., Drenos F., Hafez H., Humphries S.E. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg 2008, 35:19-30.
21. Korcz A., Mikołajczyk-Stecyna J., Gabriel M., Zowczak-Drabarczyk M., Pawlaczyk K., Kalafirov M., Oszkinis G., Słomski R. Angiotensin-converting enzyme (ACE, I/D) gene polymorphism and susceptibility to abdominal aortic aneurysm or aortoiliac occlusive disease. J Surg Res 2009, 153:76-82.
22. Lucarini L., Sticchi E., Sofi F., Pratesi G., Pratesi C., Pulli R., Gensini G.F., Abbate R., Pepe G., Fatini C. ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm. Atherosclerosis 2009, 202:205-210.
23. Lesauskaite V., Epistolato M.C., Castagnini M., Urbonavicius S., Tanganelli P. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Hum Pathol 2006, 37:1076-1084.
24. Lu H., Rateri D.L., Cassis L.A., Daugherty A. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep 2008, 10:99-106.
25. Hamdi H.K., Castellon R.A. Genetic variant of ACE increases cell survival: a new paradigm for biology and disease. Biochem Biophys Res Commun 2004, 318:187-191.